Beneficiary Inducement
Beneficiary inducement is the offering or transfer of remuneration to a Medicare or Medicaid beneficiary that the offeror knows or should know is likely to influence the beneficiary's choice of a particular provider, practitioner, or supplier. It is prohibited by the beneficiary-inducement civil monetary penalty at 42 U.S.C. § 1320a-7a(a)(5), and “remuneration” is defined to include waivers of coinsurance and deductible amounts. Unlike the Anti-Kickback Statute, which targets remuneration to a referral source, this prohibition targets remuneration offered to the patient.
Updated
Beneficiary inducement is the offering or transfer of something of value to a beneficiary of a federal health care program in a way that is likely to steer that person's choice of where to get care. The prohibition is a civil monetary penalty in the Civil Monetary Penalties Law — section 1128A(a)(5) of the Social Security Act, 42 U.S.C. § 1320a-7a(a)(5), added by HIPAA in 1996 — and it reaches a person who offers or transfers remuneration to a Medicare or Medicaid beneficiary that the person “knows or should know is likely to influence” the beneficiary to order or receive items or services from a particular provider, practitioner, or supplier.
“Remuneration” is defined broadly at 42 U.S.C. § 1320a-7a(i)(6): it includes the waiver of coinsurance and deductible amounts, and transfers of items or services for free or for other than fair market value. The intent bar is low — the statute defines “should know” to mean acting in deliberate ignorance or reckless disregard of the truth, and states that no proof of specific intent to defraud is required.
In practice
The most common way a billing operation encounters this rule is the routine waiver of a patient's cost-sharing, which the statute names as remuneration. A narrow exception exists for a waiver that is not advertised, not routine, and based on an individualized, good-faith determination of the patient's financial need or the failure of reasonable collection efforts. There is also room for gifts of nominal value under OIG guidance — never cash or cash equivalents, and subject to per-item and annual limits OIG sets and periodically revises — and for remuneration that promotes access to care and poses a low risk of harm.
The prohibition applies to remuneration offered to the patient, so it complements rather than duplicates the Anti-Kickback Statute. It is enforced by the HHS Office of Inspector General through civil monetary penalties and possible exclusion from the federal programs, not by criminal prosecution.
Commonly confused with
- Anti-Kickback Statute: The Anti-Kickback Statute is a criminal law aimed at remuneration paid to induce or reward referrals or program business — typically between a provider and a referral source. The beneficiary-inducement penalty is a civil monetary penalty aimed at remuneration offered to the patient to influence the patient's own choice of provider. The same routine copay waiver can implicate both.
- Cost sharing: Cost sharing — a copayment, coinsurance, or deductible — is the patient's share of a covered charge. Waiving it is one form of remuneration that can trigger the beneficiary-inducement prohibition; the term here is the prohibition, not the practice.